Business Context and Reporting Period
This Form 8-K Current Report was filed by Archer-Daniels-Midland Company (ADM) on July 23, 2026, covering events reported as of July 17, 2026. The filing primarily addresses the appointment of a new senior executive officer.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements.
Material Changes
The material change disclosed is the appointment of Jeffrey Rowe as Executive Vice President and Chief Operating Officer, effective August 17, 2026. Mr. Rowe is transitioning from his role as Chief Executive Officer of Syngenta Group.
Management Commentary and Compensation Details
Management has established a comprehensive compensation package for Mr. Rowe, detailed as follows:
- Base Salary: $1,200,000 annually.
- Cash Incentive: Target of 175% of base salary ($2,100,000), paid pro rata for 2026.
- Annual Equity Target: $12,500,000.
- 2026 Equity Grant: $11,100,000 total value (60% Performance Stock Units, 40% Restricted Stock Units), vesting over three years.
- Make-Whole Awards:
- Cash bonus of $2,200,000 payable in January 2027.
- Equity award of $16,690,000 in RSUs, vesting 40% at 5 months and 60% at 17 months.
- Benefits: Relocation benefits and participation in standard employee and executive benefit plans.
The filing notes there are no family relationships between Mr. Rowe and current directors or officers, and no undisclosed arrangements influenced his selection.
Investor Verification Checklist
- Verify the total potential compensation value, including the $16.69 million make-whole equity award.
- Review the specific vesting conditions and "Cause" or "Good Reason" termination clauses in the attached Offer Letter (Exhibit 10.1).
- Confirm the effective start date of August 17, 2026, and the transition timeline from Syngenta Group.
- Assess the impact of the pro-rated 2026 cash incentive calculation on immediate cash flow obligations.